Mobocertinib (TAK-788) in epidermal growth factor receptor gene (EGFR) exon 20 insertion mutation-positive (EGFRex20ins+) metastatic non-small cell lung cancer (mNSCLC): results from the platinum-pretreated patients (PPP) cohort of a phase 1/2 study
Year: 2022
Type: article
Source: Lung Cancer
Authors: Sanjay Popat, Suresh Ramalingam, Tae Min Kim, James Yang, Gregory Riely, Tarek Mekhail, Danny Nguyen, Maria Rosario Garcia Campelo, Enriqueta Felip, Alexander Spira, Zofia Piotrowska, Lyudmila Bazhenova, Sylvie Vincent, Shu Jin, Celina Griffin, Paul Diderichsen, Neeraj Gupta, Veronica Bunn, Jianchang Lin, Huamao Lin, Eric Churchill, Minal Mehta, Caicun Zhou, Pasi Jänne
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4211226814